See also this year's filing and all EDGAR filings for this company.
PDF Report 0001126234_2022_LUMOS_PHARMA_INC.pdf
Logs
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': inf, 'aggregate_val': 230000, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}} |
Graph
Absolute values for 0001126234, LUMOS PHARMA INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 99,677,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 79,000 |
| 3 | remainder_Assets | 556,000 |
| 4 | LiabilitiesCurrent | 5,130,000 |
| 5 | LiabilitiesNoncurrent | 6,205,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,331,000 |
| 9 | ResearchAndDevelopmentExpense | 16,246,000 |
| 10 | remainder_Expenses | -636,000 |
| 11 | remainder_Revenues | 230,000 |
| 12 | remainder_NetIncome | 281,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 100,312,000 |
| 1 | Liabilities | 11,335,000 |
| 2 | Expenses | 30,941,000 |
| 3 | Revenues | 230,000 |
| 4 | StockholdersEquity | 88,977,000 |
| 5 | NetIncome | -30,430,000 |
| 6 | ComprehensiveNetIncome | -30,430,000 |
| 7 | BaseVar | 71,549,500 |
| 8 | EconomicCapitalRatio | 2.20 |
Edgar->Model Mapping
Feature Distribution
Change over Time
